Which statement by the parent of a client with paranoid schizophrenia indicates a need for further teaching about ziprasidone?

Which statement by the parent of a client with paranoid schizophrenia indicates a need for further teaching about ziprasidone?

• A. If he experiences restlessness or muscle stiffness, he should tell the doctor.
• B. I should give him benztropine to help prevent constipation from the ziprasidone.
• C. If he becomes dizzy, I'll make sure he doesn't drive.
• D. The ziprasidone should help him be more motivated and less withdrawn.

Answer: (B)

The statement indicating a need for further teaching about ziprasidone is that the parent should give benztropine to help prevent constipation from the medication. Ziprasidone is an atypical antipsychotic that is primarily used to treat symptoms of schizophrenia and bipolar disorder. One of its side effects can be extrapyramidal symptoms (EPS), which include movement disorders such as restlessness or muscle stiffness. Benztropine is indeed used to treat such symptoms, but it is unrelated to constipation. In fact, one of the known side effects of ziprasidone can be constipation itself due to its effects on the gastrointestinal system, but benztropine does not prevent constipation. Instead, a better approach for managing constipation would be the use of dietary changes, hydration, or stool softeners rather than an anticholinergic medication. The other statements reflect appropriate understanding of ziprasidone's effects and necessary precautions. Noticing restlessness or muscle stiffness and informing a doctor indicates awareness of EPS. Acknowledging dizziness and the importance of not driving shows an understanding of the potential impact of medication on safety. Lastly, recognizing that ziprasidone may help with motivation and reduce withdrawal aligns with the goals of antipsychotic treatment,

The statement indicating a need for further teaching about ziprasidone is that the parent should give benztropine to help prevent constipation from the medication. Ziprasidone is an atypical antipsychotic that is primarily used to treat symptoms of schizophrenia and bipolar disorder. One of its side effects can be extrapyramidal symptoms (EPS), which include movement disorders such as restlessness or muscle stiffness. Benztropine is indeed used to treat such symptoms, but it is unrelated to constipation. In fact, one of the known side effects of ziprasidone can be constipation itself due to its effects on the gastrointestinal system, but benztropine does not prevent constipation. Instead, a better approach for managing constipation would be the use of dietary changes, hydration, or stool softeners rather than an anticholinergic medication.

The other statements reflect appropriate understanding of ziprasidone's effects and necessary precautions. Noticing restlessness or muscle stiffness and informing a doctor indicates awareness of EPS. Acknowledging dizziness and the importance of not driving shows an understanding of the potential impact of medication on safety. Lastly, recognizing that ziprasidone may help with motivation and reduce withdrawal aligns with the goals of antipsychotic treatment,